4//SEC Filing
Oltmans Curtis Gale 4
Accession 0001562180-19-000816
CIK 0001100412other
Filed
Feb 6, 7:00 PM ET
Accepted
Feb 7, 4:30 PM ET
Size
9.9 KB
Accession
0001562180-19-000816
Insider Transaction Report
Form 4
Oltmans Curtis Gale
General Counsel
Transactions
- Exercise/Conversion
Common Stock
2019-01-29$8.94/sh+11,100$99,234→ 15,021 total - Exercise/Conversion
Common Stock
2019-02-05$8.94/sh+40,000$357,600→ 55,021 total - Sale
Common Stock
2019-02-05$20.00/sh−40,000$800,000→ 15,021 total - Exercise/Conversion
Stock Option (Right to Buy)
2019-02-05−40,000→ 363,900 totalExercise: $8.94Exp: 2027-08-15→ Common Stock (40,000 underlying)
Footnotes (2)
- [F1]These trades were made pursuant to a Rule 10b5-1 trading plan.
- [F2]The option vests in four equal annual installments beginning August 15, 2018.
Documents
Issuer
ARRAY BIOPHARMA INC
CIK 0001100412
Entity typeother
Related Parties
1- filerCIK 0001714982
Filing Metadata
- Form type
- 4
- Filed
- Feb 6, 7:00 PM ET
- Accepted
- Feb 7, 4:30 PM ET
- Size
- 9.9 KB